Leslie Wainwright is chief funding and innovation officer, Parkland Center for Clinical Innovations, Dallas. Her experience includes academic research, pharma/biotechnology and healthcare delivery; working with startups and multinational executive teams in creating growth strategies and alternative business models; and evaluating emerging clinical\care delivery technologies. Dr. Wainwright speaks on future of healthcare, enabling technologies, disruptive innovation and emerging business models. Prior to joining Parkland, she oversaw RTI International’s Innovation Advisors health practice, guiding the development and adoption of healthcare innovation. She has held executive roles with Sg2, AVIA and Business Models Inc. Dr. Wainwright earned her doctorate in microbiology at Northwestern University, and completed postdoctoral research training at the University of Maryland’s Center for Vaccine Development.

 

Dr. Wainwright serves as faculty for the following ACHE seminars: